The Joint Corp. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 4 Fair Values set on narratives written by author
US$10.03
-1.39 (-12.17%)
11.4% overvalued intrinsic discount
US$9.00
Fair Value
Price US$10.03
AnalystLowTarget US$9.00
AnalystHighTarget US$14.00
AnalystConsensusTarget US$10.75
Fair ValueUS$9.00
Share Pricen/a
JYNT Community Narratives
AN

Fair Value US$9 11.4% overvalued intrinsic discount
Refranchising And Flat Revenues Will Shape A Cautious Yet Stable Future Outlook
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN

Fair Value US$14 28.4% undervalued intrinsic discount
Pain Relief Marketing And Refranchising Will Transform This Chiropractic Network Over The Next Decade
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN

Fair Value US$10.75 6.7% undervalued intrinsic discount
Franchising Shift And Membership Demand Will Drive Long Term Earnings Power
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Refranchising And Flat Revenues Will Shape A Cautious Yet Stable Future Outlook
Catalysts About Joint The Joint Corp. franchises chiropractic clinics that focus on affordable, routine care for pain relief and wellness.Read more
28
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN

US$9
11.4% overvalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
-0.36% p.a.
Profit Margin
23.89%
Future PE
12.02x
Price in 2029
US$11.29
Pain Relief Marketing And Refranchising Will Transform This Chiropractic Network Over The Next Decade
Catalysts About Joint The Joint Corp. operates a national network of franchised chiropractic clinics that offer affordable, routine care focused on pain relief and ongoing wellness.Read more
9
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN

US$14
28.4% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
4.53% p.a.
Profit Margin
20.17%
Future PE
19.18x
Price in 2029
US$17.57
Franchising Shift And Membership Demand Will Drive Long Term Earnings Power
Catalysts About Joint Joint operates a nationwide network of franchised chiropractic clinics focused on affordable, convenient, membership-based care. What are the underlying business or industry changes driving this perspective?Read more
5
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN

US$10.75
6.7% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
2.58% p.a.
Profit Margin
23.2%
Future PE
13.55x
Price in 2028
US$13.15
Trending Discussion
Recently Updated Narratives
AN

Refranchising And Flat Revenues Will Shape A Cautious Yet Stable Future Outlook
Fair Value: US$9 11.4% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN

Pain Relief Marketing And Refranchising Will Transform This Chiropractic Network Over The Next Decade
Fair Value: US$14 28.4% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN

Franchising Shift And Membership Demand Will Drive Long Term Earnings Power
Fair Value: US$10.75 6.7% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
The Joint Corp. Key Details
About JYNT
- Founded
- 2010
- Employees
- 590
- CEO
- Website
View website
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company was incorporated in 2010 and is headquartered in Scottsdale, Arizona.